A former peptide chemist covered the AAPM conference as the FDA weighs letting pharmacies compound BPC-157 and others, and found sizable gaps in the evidence advocates cite.
Recap by typeshit. Full story at MedShadow Foundation.
NewsNation reports doctors' guidance on pausing GLP-1 medications ahead of pregnancy. The full story has their reasoning.
The piece examines claims that taking smaller GLP-1 doses brings weight loss with fewer side effects, and asks how well that holds up.
10 News reports Australians are ending up in hospital after using unregulated peptides, prompting warnings from two state health departments.
IE Lifestyle reports on new research tying GLP-1 use to nail and hair problems, with two experts weighing in on the findings.
ASU's Justin Bina told the New York Post that people starting GLP-1 drugs become willing to pay more per pound for certain proteins, even as cattle stocks hit a 75-year low.
A local feature on clinics in Sarasota using peptides for recovery, hormones and wellness. The claims come from the practitioners and are not backed by cited evidence.
Loading…